Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: July 2022
Delayed cord blood clamping: a health boost for babies, and potentially for others – La Crosse Tribune
Posted: July 19, 2022 at 2:20 am
In utero, an umbilical cord is the babys lifeline and after birth, it still has the potential to sustain life.
Rather than cutting the cord immediately, Dr. Dennis Costakos, neonatologist at Mayo Clinic Health System La Crosse, advocates for delaying clamping for 30 seconds to a minute to increase distribution of blood to the infant rather than leaving this precious blood in the placenta. Clamped at 10 to 15 seconds, 67% of the umbilical cord blood will go directly to the infant, a percentage that increases to 80% at the 60-second mark.
Costakos implemented delayed cord clamping at Mayo Clinic Health System in La Crosse in 2006 after presenting his research. The process has been around for hundreds of years but was not always common. In the 1960s, early cord clamping was the norm due to concerns about maternal and infant outcomes, but studies over the decades led to making delayed clamping standard some 50 years later.
People are also reading
For babies born at full term, the extra blood can improve iron stores and may enhance development.
Dennis Costakos
For babies born prematurely, waiting to clamp can decrease risk of some potentially life threatening complications of being born earlier than full term. Both the American College of Obstetricians and Gynecologists Committee on Obstetric Practice and the American Academy of Pediatrics recommend delayed cord clamping, with a 2012 systematic review of 15 studies showing a wait of 30 to 180 seconds had significant health benefits for preterm infants.
Among the infants studied, cord blood was found to improve transitional circulation and red blood cell volume, and reduce the chances of necrotizing enterocolitis (inflammation of intestinal tissue) and intraventricular hemorrhage.
It is possible there will be enough cord blood to both stay with the baby and be saved or donated. The cord blood can be stored in a private bank for use to help a family member with a qualifying condition, or donated to a public cord blood bank to aid in treating others.
If a sibling is currently suffering from leukemia, sickle cell disease, Hodgkins lymphoma or thalassemia, physicians may after discussion with the siblings care team and looking at the best treatment options recommended saving it for the sister or brother.
Cord blood banking for personal use is not recommended, as it is a highly costly service up to $2,000 to start, and additional fees of around $100 annually and not covered by insurance. The chance that the baby may later need their own stems cells is miniscule, and if requiring medical intervention a donors stem cells would likely be used.
The chances that you would ever call for the cord blood would not be more than one in 10,000, maybe even as low as one in 250,000, Costakos says.
Donations, according to the Health Resources and Services Administration, are in need. Around 70% of patients do not have a fully matched family member, and for them A transplant of bone marrow or cord blood from an unrelated donor may be their only transplant option. The National Cord Blood Inventory aims to collect and store at least 150,000 new cord blood units, with donations from members of diverse racial and ethnic groups especially needed.
Donating, however, may not be feasible. Costakos notes moms-to-be could be disqualified from donating to public banks due to existing health conditions, and travel would be necessary as there are no collection centers in Wisconsin and Minnesota.
Should they opt in to bank or donate, parents must express their wishes to save the cord blood in advance. The collection process is painless for the baby, Costakos says, as there are no nerve fibers in the umbilical cord.
Blood is drained from the umbilical cord with a needle, and a special collection bag is attached, Costakos says. After the bag is sealed, the placenta is delivered. The process takes about 10 minutes.
In some cases, immediate cord clamping may be necessary, such as if the cord placenta has already separated from the baby. This condition, called abruptio placenta, can interrupt or prevent oxygen and nutrient supply to the baby and cause the mother to bleed excessively.
For more information on cord blood donation, visit https://bloodstemcell.hrsa.gov/.
UW-La Crosse staff and faculty deliver gift baskets Tuesday afternoon at Gundersen.
Donations from the UW-L campus community are delivered at Gundersen.
Nurses and a representative from the Gundersen Medical Foundation met the UW-L students and faculty.
Donations from the UW-L campus community are delivered at Gundersen.
The gifts including snacks, games, gift cards, thank-you notes and more were donated by the UW-L campus community.
Donations from the UW-L campus community are delivered at Gundersen.
Donations from the UW-L campus community are delivered at Gundersen.
The gifts including snacks, games, gift cards, thank-you notes and more were donated by the UW-L campus community.
Donations from the UW-L campus community.
Nurses and a representative from the Gundersen Medical Foundation met the UW-L students and faculty.
Subscribe to our Daily Headlines newsletter.
Go here to see the original:
Delayed cord blood clamping: a health boost for babies, and potentially for others - La Crosse Tribune
Posted in Wisconsin Stem Cells
Comments Off on Delayed cord blood clamping: a health boost for babies, and potentially for others – La Crosse Tribune
The engineer who teaches our bodies to heal themselves – EL PAS USA
Posted: July 19, 2022 at 2:18 am
The ancient Egyptians used sutures made of linen and animal sinew. In South Africa and India, the heads of large biting ants were used as clamps to hold the edges of wounds together. For centuries, humans have used natural and artificial materials to repair all kinds of tissues. More than 4,000 years later, American engineer Kristi Anseth is studying how newer, more sophisticated biomaterials assist in regenerating cartilage, help bones heal faster, and provide a better understanding of some diseases.
Biomaterials can play a key role in helping our bodies heal themselves, said Anseth, who received the 2020 LOral-UNESCO For Women in Science international award in late June (after a two-year pandemic hiatus). In an interview with EL PAS conducted at the awards ceremony in Paris, the researcher who specializes in regenerative medicine and tissue engineering, and also designs synthetic materials that imitate our tissues, said, We are using materials designed for textile products like mattresses or clothing, and making them interact with the human body.
Biomaterials can be used to deliver molecules that help [injured or diseased] tissues heal faster, said Anseth, who is also an Associate Professor of Surgery at the University of Colorado in the United States. When you only inject cells and nothing else, sometimes they dont survive very well on their own. They need a three-dimensional environment a biomaterial that can provide the scaffolding and instructions on where and when to grow the right kind of tissue.
Many types of biomaterials are commonly used today heart valves, hip joint replacements, and dental implants. They are made from cells, living tissues, metals, ceramics, plastics, and glass. The US National Institute of Biomedical Imaging and Bioengineering notes that biomaterials can be used in molded or machined parts, coatings, fibers, films, foams, and fabrics for biomedical products and devices. Anseth highlights the potential of degradable sutures that can bind tissues together and dissolve once they have healed.
Anseth explains how biomaterials are used to heal arthritis, an inflammation of the joints that can cause pain and swelling. What usually happens, says Anseth, is that the cartilage that lines a joint like the knee wears down. When you dont have that lubricating cartilage surface in between and bones are grinding against each other its painful, she said. But we have a lot of extra cartilage in our body so we can take it from somewhere else, grow the cells in a bioreactor, and insert them into the joint to grow and regenerate that cartilage surface.
In addition, there are some proteins called growth factors, which can also help tissues and cells grow and heal themselves. Anseth says that these can be useful for fractured bones. Although our bones can usually heal on their own, sometimes a cast or plates and screws are needed. Its a long [healing] process, she said, and sometimes large defects caused by a car accident or bone cancer may not heal very well.
Anseth said a growth factor found in bone marrow can be useful in these cases, but theres a catch. You cant administer it on its own for a major bone injury because it could degrade. Thats where biomaterials come in. They can be used to deliver that [growth] factor locally for longer periods of time and at the right dose, time, and place.
Despite their great potential, biomaterials also have limitations. There is a risk of infection if they are not biocompatible. The presence of exogenous materials in the human body dates back to prehistoric times, as documented in a study published in Processes, a scientific journal. A spearhead embedded in the hip of Kennewick Man, a 9,000-year-old skeleton found in Washington state (US), and the use of carbon particles for tattooing are examples of foreign objects that were tolerated by human bodies centuries ago.
Two key factors determine the biocompatibility of a material, according to a study published in Materials: host reaction and degradation in the body. Sometimes, says Anseth, its difficult to get biomaterials to degrade at the same rate as new tissue growth. Moreover, getting a biomaterial to have all the desired properties is tricky. Bones, for example, are really strong and most biomaterials are not as strong or dont have the same properties, said Anseth.
More research is still needed to unravel all the mysteries of the human body. Anseth said: We have regenerated skin, cartilage, and blood vessels, and we have also helped bones heal faster. But we still need to do more [research]. For example, why doesnt the heart regenerate after a heart attack in the same manner as the skeletal muscles we use for walking and exercise?
Anseth foresees significant advances in medicine over the next 10 years. Were going to figure out how we can intervene earlier to get muscles to grow, repair cartilage. or heal nerves things that arent possible right now. One of her most ambitious goals is to counteract age-related health problems. Age, a risk factor for multiple chronic diseases, is often accompanied by a loss of body mass.
As we age, something happens to our cells, said Anseth. They have divided many times over a lifetime, and are no longer as active or able to repair themselves. Biomaterials could provide young stem cells to help muscles grow back. Aging is a complex natural process that we cant necessarily reverse, but we can improve the quality of life for people experiencing degeneration in their joints, muscles and hearts.
Link:
The engineer who teaches our bodies to heal themselves - EL PAS USA
Posted in Colorado Stem Cells
Comments Off on The engineer who teaches our bodies to heal themselves – EL PAS USA
Control in Healthcare: History and Reclamation of Bodily Autonomy – Non Profit News – Nonprofit Quarterly
Posted: July 19, 2022 at 2:18 am
This is the introduction and first installment of a five-part series, Reclaiming Control: The History and Future of Choice in Our Health, examining how healthcare in the US has been built on the principle of imposing control over body, mind, and expression. However, that legacy stands alongside another: that of organizers, healers,and care workers reclaiming control over health at both the individual and systems levels.Published in five monthly installments from July to November 2022, this series aims to spark imagination amongst NPQs readers and practitioners by speaking to both histories, combining research with examples of health liberation efforts.
Last week, as announcements that the Supreme Court had overturned Roe v. Wade roiled my phone, a flood of emotions flowed through my internal neural network as well as the external network I was connected tomillions of us processing together in real time.
Despite knowing for months if not years that such a Supreme Court ruling would arrive, the news was still shocking: sparking collective and individual fury at being ignored, subdued, and overridden, as well as grief for the past and anxiety about what the future might now hold.
But what I felt most, deep in my gut, was a sharp and terrifying loss of control.
The truth is, when it comes to my bodythat thing with which we have our most intimate relationship (and particularly for women of color, often our most complicated relationship)I know that feeling all too well.
I experienced loss of control in a pediatricians office, as my doctor peered at me disbelievingly, dismissing my fatigue as teenage girl angst (it turned out to be the symptom of a severe, undiagnosed case of mononucleosis that landed me in the emergency room). I felt it again when an insurance company hit me with a five-figure bill after a scary, unexpected medical procedure and demanded immediate payment. Most recently, I remember the dread of the earliest days of the pandemic, alone in my apartment, trying to make sense of the painful headlines.
As a public health practitioner and researcher, I have spent my career working both inside healthcare systems and with community-based organizations, fighting to hold healthcare institutions to transparency and different ways of work. Throughout those 16 years, I have heard many harrowing experiencesdenial of care, lack of informed consent, explicit racism and xenophobia, medical bankruptcyechoed across movement spaces and repeated in the narratives of women and gender nonconforming folks of color across the country. Despite inhabiting our own bodies every day, when we seek to make choices around counsel and care, we are frequently questioned, misdiagnosed, condescended to, harmed, or even left to die.
Unfortunately, this present-day reality is just the latest manifestation of a longstanding legacy of control that is fundamental to the design and delivery of healthcare in the United States. This system surrounds even individual clinicians, care workers, and healers who seek to look after us with heartfelt compassion and skill (and who, especially in the past 2.5 years, have done so at risk to themselves). It has been shaped by complex layers of history: racialized capitalisms reduction of human bodies to commodified objects; patriarchy and religion working lockstep to dehumanize women and rigidify gender roles; and the weighting of professional over lived experiences. Each of these forces shapes our reality of and debates about what it means to control our own voices, minds, and bodiesand, in turn, to have control over our very being.
In The Birth of the Clinic, which traces the rise of the medical gaze and the detached clinification of the body in the late 18th century, Michel Foucault shares French doctor and politician Francois Lanthenas reflection on the relationship between liberty and health. Man will be totally and definitely cured only if he is first liberatedif medicine could be politically more effective, it would no longer be indispensable medically. And in a society that was free at last, in which inequalities were reducedthere would no longer be any need for academies and hospitals.
In 2022, of course, we are nowhere near this idyllic scenario of widespread liberation, although there is a long legacy of organizing and movement building that has pulled us ever toward it. Poverty, structural racism, and other forms of systemic oppression are root causes of health inequities, thereforeas Foucault points outa healthcare system designed primarily to treat illnessas opposed to the social causes of illness could only ever serve as a band-aid. Indeed, by prioritizing the medical gaze, which turns people into objects of study, healthcare itself perpetuates those same oppressions.
In the late 1700s, British settlers opened almshouses and asylums as places of last refuge and hospice for the poor, those with disabilities and chronic illness, and the elderly. Medical history literature outlines how these asylums, which were typically run by religious and charitable organizations, were characterized by poor healthcare and living standards and often placed patients of color into harmful conditions, despite ostensibly providing them care. This devaluing of the human experience undergirds much of our national dialogue about and experiences of health and choice today.
As white supremacist medical racism of the 1800s coalesced against a backdrop of slavery and Indigenous genocide, science was deployed to embed falsehoods about Black and Indigenous people into the national consciousnesssuch as categorizing runaway attempts by slaves as a curable disease. Inhumane, coercive medical experimentation on people of color was justified via recourse to myths about Black peoples brain size and high pain thresholds, myths that still permeate medicine today. This early era of medicine, explicit in its attempts to control large segments of the population, morphed during the Jim Crow era into state-sanctioned medical projects such as the Tuskegee Experiment, in which incarcerated Black men were used as objects with which to study syphilis, and into private sector exploitation, such as the use of stem cells taken from patient Henrietta Lacks without her knowledge or consent, which went on to become foundational to biological research.
A core component of control in the healthcare system involves control over the bodies of those who can birth. Throughout the first half of the 20th century, BIPOC women and women with disabilities experienced forced sterilization on a mass scale, with the Supreme Court upholding in 1927 a states right to sterilize people designated as unfit to procreate. Far from a historic phenomenon, this practice has continued into the present day, with women who are incarcerated or detained for immigration purposes particularly affected.
Today, we see the products of these histories in our maternal mortality crisis, as mothers of color, particularly Black mothers, experience the hazardous impacts of structural racism both in and outside the medical system. Even in the shift that healthcare is now making towards acknowledging and investing in social determinants of health such as food, housing, and transportation, medicalizationi.e., when nonmedical problems becomedefinedand treated as medical problemsis common.
As advocates have pointed out, many new efforts in the social determinants of health (SDH) sector deploy surveillance data and tracking of BIPOC communities to generate profits or justify algorithms. Virginia Eubanks, author of Automating Inequality, ties this trend to our countrys history dating all the way back to the almshouses. Eubanks writes, Technologies of poverty management are not neutral. They are shaped by our nations fear of economic insecurity and hatred of the poor.
What these histories make clear is that, since our countrys founding, choice and control have been juxtaposed in our philosophies and practices of health: choices made by one set of people with political and economic power to control so many others.
Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.
By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.
Perhaps the most flummoxing thing about this history is that so much of our health and healing already feels out of our control. Stripping away the social complexities and constructs, we allas people and caregiversexperience the ups and downs of living in mortal bodies (and minds) that we do not completely understand.
Not all cultures, of course, strive to have such an iron grip on the body. White-dominant, Western societies like the United States frequently view death as a final, medically defined state, and therefore healthcare as a tool to prolong life. On the other hand, non-Western cultures, dating back thousands of years, often consider the condition of the physical body to be more cyclical and impermanent.
But liberation as an aspect of wellbeing is universal across humans: the vulnerable desire to thrive, to be autonomous, to live fully. And so, it is heartbreaking and dehumanizing whenas has happened across the centuries with scientific experimentation and reproductive rightswellbeing is not only obstructed but actively taken away.
Yet other stories run alongside this history of oppression, stories of reclamation and healing. For centuries, women and gender nonconforming people of color (and their allies) have fought in our country and globally to wrest back control over who and what shapes health.
Over the course of the next few articles in this series, we will delve into different corners of that resistance space, exploring organizations that are working across its many branches. These branches are:
In Baltimore, where I live, there is a long legacy of community members who have built outside of traditional systems in order to preserve bodily autonomy and traditional visions of healing. The Village of Love and Resistance in East Baltimore, for example, uses a community ownership and investment structure alongside a radical organizing model to create spaces of traditional healing as well as local wealth building.
Leaders in the healing justice movement, as well as healers of all kinds who are working to bring ancestral and other ways of knowing to health (even amidst the noise of the commercialized, white-dominated wellness industry) also continue to build their own systems. Harriets Apothecary, a self-organized healing community that seeks to build independence from the medical industrial complex, brings a Black, queer, feminist analysis to its programming, which includes advocacy, apprenticeship, healing spaces, consulting, political education, and more.
Alongside those who are building outside of systems, many are also working to fundamentally reclaim the mechanisms of our traditional healthcare systems by introducing accountability and shifting control from healthcare institutional leaders to community members visioning new ways of health.
Shift Health Accelerator, a distributed leadership network that grew out of the Robert Wood Johnson Foundations Culture of Health Leader program, partners with organizations to explore community ownership over healthcare decision making, funding flows, and data. Through democratic processes like participatory grant-making and a learning network focused on political education and history, the organization is developing standards for healthcare accountability.
With the exception of the LGBTQ+ communitys organizing and political mobilization to achieve victories in HIV/AIDS treatment, targeting control within the healthcare system has historically not been a large-scale focus of power-building entities. The Center for Health Progress in Colorado is working to build a base of Latinx immigrants as well as allied healthcare professionals who can hold health systems and other healthcare stakeholders accountable for historical control dynamics with respect to immigrant health and other issues.
A fundamental mechanism of control in healthcare has been that of the clinician-patient relationship, through which many past harms have been enacted. A new generation of healthcare professionals is grappling with this legacy, decolonizing education and the paternalism that has pervaded medicine. People Power Health brings an organizing analysis to healthcare professionals and clinicians in particular, deploying trainings and civic participation to enlist them in health justice efforts.
The Freedom School for Intersectional Medicine & Health Justice, based out of the Bay Area, is working toward a medical and public health praxis that centers the experiences of marginalized women and communities of color. Through organizing, institutes, political education syllabus, and more, they are working to flip existing paradigms of research and education for healthcare and public health practitioners.
Finally, underlying this practical work is another component of systems change: narrative change. Authors like Rupa Marya and Raj Patel, whose book Inflamed: Deep Medicine and the Anatomy of Injustice explores the legacy of colonialism in healthcare, represent a wave of scholars, researchers, journalists, and others exposing the stories that prop up control within healthcare.
Organizers, too, are working to shift the dominant narratives surrounding health in the United States. SisterSong, a Southern-based, reproductive justice collective, is redefining the birth justice movement by centering birthing as a fundamental human rights issue and by building power across a variety of frontiers. This collective also centers the role of art through its Artists United for Reproductive Justice program, which creates and disseminates reproductive justice artwork that can deepen activism and reshape dominant culture.
In this time, many of us are looking for ways to imagine togetherto look beyond the status quo to a paradigm in which liberation and health are one and the same, rather than forced apart. These examples, and many others, provide a vision and showcase a creativity that can illuminate a way forward, collectively.
Posted in Colorado Stem Cells
Comments Off on Control in Healthcare: History and Reclamation of Bodily Autonomy – Non Profit News – Nonprofit Quarterly
Researchers find fabrication of artificial heart for transplant – ThePrint
Posted: July 19, 2022 at 2:16 am
Washington [US], July 18 (ANI): Unlike other organs, the heart cannot heal itself after injury. Heart disease is the top cause of mortality in the U.S and is particularly deadly. For this reason, tissue engineering will be crucial for the development of cardiac medicine, ultimately leading to the mass production of a wholesale fabrication of an entire human heart for transplant.
The findings of the research were published in Science.
To build a human heart from the ground up, researchers need to replicate the unique structures that make up the heart. This includes recreating helical geometries, which create a twisting motion as the heart beats. Its been long theorized that this twisting motion is critical for pumping blood at high volumes, but proving that has been difficult, in part because creating hearts with different geometries and alignments has been challenging.
Now, bioengineers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have developed the first biohybrid model of human ventricles with helically aligned beating cardiac cells, and have shown that muscle alignment does, in fact, dramatically increases how much blood the ventricle can pump with each contraction.
This advancement was made possible using a new method of additive textile manufacturing, Focused Rotary Jet Spinning (FRJS), which enabled the high-throughput fabrication of helically aligned fibers with diameters ranging from several micrometers to hundreds of nanometers. Developed at SEAS by Kit Parkers Disease Biophysics Group, FRJS fibers direct cell alignment, allowing for the formation of controlled tissue engineered structures.
This work is a major step forward for organ biofabrication and brings us closer to our ultimate goal of building a human heart for transplant, said Parker, the Tarr Family Professor of Bioengineering and Applied Physics at SEAS and senior author of the paper.
This work has its roots in a centuries old mystery. In 1669, English physician Richard Lower a man who counted John Locke among his colleagues and King Charles II among his patients first noted the spiral-like arrangement of heart muscles in his seminal work Tractatus de Corde.
Over the next three centuries, physicians and scientists have built a more comprehensive understanding of the hearts structure but the purpose of those spiraling muscles has remained frustratingly hard to study.
In 1969, Edward Sallin, former chair of the Department of Biomathematics at the University of Alabama Birmingham Medical School, argued that the hearts helical alignment is critical to achieving large ejection fractions the percentage of how much blood the ventricle pumps with each contraction.
Our goal was to build a model where we could test Sallins hypothesis and study the relative importance of the hearts helical structure, said John Zimmerman, a postdoctoral fellow at SEAS and co-first author of the paper.
To test Sallins theory, the SEAS researchers used the FRJS system to control the alignment of spun fibers on which they could grow cardiac cells.
The first step of FRJS works like a cotton candy machine a liquid polymer solution is loaded into a reservoir and pushed out through a tiny opening by centrifugal force as the device spins. As the solution leaves the reservoir, the solvent evaporates, and the polymers solidify to form fibers. Then, a focused airstream controls the orientation of the fiber as they are deposited on a collector. The team found that by angling and rotating the collector, the fibers in the stream would align and twist around the collector as it spun, mimicking the helical structure of heart muscles.
The alignment of the fibers can be tuned by changing the angle of the collector.
The human heart actually has multiple layers of helically aligned muscles with different angles of alignment, said Huibin Chang, a postdoctoral fellow at SEAS and co-first author of the paper. With FRJS, we can recreate those complex structures in a really precise way, forming single and even four chambered ventricle structures.
Unlike 3D printing, which gets slower as features get smaller, FRJS can quickly spin fibers at the single micron scale or about fifty times smaller than a single human hair. This is important when it comes to building a heart from scratch. Take collagen for instance, an extracellular matrix protein in the heart, which is also a single micron in diameter. It would take more than 100 years to 3D print every bit of collagen in the human heart at this resolution. FRJS can do it in a single day.
After spinning, the ventricles were seeded with rat cardiomyocyte or human stem cell derived cardiomyocyte cells. Within about a week, several thin layers of beating tissue covered the scaffold, with the cells following the alignment of the fibers beneath.
The beating ventricles mimicked the same twisting or wringing motion present in human hearts.
The researchers compared the ventricle deformation, speed of electrical signaling and ejection fraction between ventricles made from helical aligned fibers and those made from circumferentially aligned fibers. They found on every front, the helically aligned tissue outperformed the circumferentially aligned tissue.
Since 2003, our group has worked to understand the structure-function relationships of the heart and how disease pathologically compromises these relationships, said Parker. In this case, we went back to address a never tested observation about the helical structure of the laminar architecture of the heart. Fortunately, Professor Sallin published a theoretical prediction more than a half century ago and we were able to build a new manufacturing platform that enabled us to test his hypothesis and address this centuries-old question.
The team also demonstrated that the process can be scaled up to the size of an actual human heart and even larger, to the size of a Minke whale heart (they didnt seed the larger models with cells as it would take billions of cardiomyocyte cells).
Besides biofabrication, the team also explores other applications for their FRJS platform, such as food packaging. (ANI)
This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content.
The rest is here:
Researchers find fabrication of artificial heart for transplant - ThePrint
Posted in Alabama Stem Cells
Comments Off on Researchers find fabrication of artificial heart for transplant – ThePrint
GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
Posted: July 19, 2022 at 2:15 am
MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce that we are partnering with Melbourne based Siles Health, a leading Obstetrics and Gynaecology practice, to implement geneType Multi-Risk Test as part of their commitment to remain at the forefront of contemporary personalised patient health care.
Read the original:
GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
Posted in Global News Feed
Comments Off on GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation
Posted: July 19, 2022 at 2:15 am
IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today reported that the first patient has been dosed in a Phase 1b study to evaluate tegoprubart in patients undergoing kidney transplantation.
Read the original post:
Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation
Posted in Global News Feed
Comments Off on Eledon Pharmaceuticals Announces the First Patient Dosed in Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-601 and Cetuximab Combination
Posted: July 19, 2022 at 2:15 am
ERAS-601, a potential best-in-class SHP2 inhibitor, is being investigated alone and in combination in the ongoing FLAGSHP-1 Phase 1/1b trial
Read the rest here:
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-601 and Cetuximab Combination
Posted in Global News Feed
Comments Off on Erasca Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate ERAS-601 and Cetuximab Combination
AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid
Posted: July 19, 2022 at 2:15 am
Files Complaint in Federal Court to Compel Activist Group to Reveal True Intentions – Including a Potential Hostile Takeover of the Company – and Prevent Group from Continued Violations of Federal Securities Laws and SEC and Florida Injunctions
See the article here:
AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid
Posted in Global News Feed
Comments Off on AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
Posted: July 19, 2022 at 2:15 am
- Global Phase 2 placebo-controlled trial enrolled twice as fast as the industry average, establishing a roadmap for future studies -
Posted in Global News Feed
Comments Off on Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Posted: July 19, 2022 at 2:15 am
Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is ready for inspection Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is ready for inspection
Read more here:
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Posted in Global News Feed
Comments Off on Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
